Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder (NCT06359340)
Identifying Optimal Psychosocial Interventions for Patients Receiving Office-Based Buprenorphine
🩺 Plain-English Summary (8th-Grade Level)
Current clinical guidelines for medication assisted treatment (MAT) of opioid use disorder (OUD) recommend that treatment include a psychosocial component to help address psychological factors related to addiction. However, a knowledge gap exists regarding the most effective forms of psychosocial intervention and what interventions are most effective for different types of patients. This gap represents a significant barrier to the widespread implementation of effective office-based opioid treatment (OBOT) with buprenorphine, which is important to improving opioid treatment and responding to the critical needs of individuals living with OUD. The overarching goal of this patient-centered research is to address the diverse needs and preferences of OUD patients in regards to psychosocial approaches and to overcome the "one-size-fits-all" strategies that are typically used to treat OUD. Importantly, the investigators arrived at this goal, in part, through collaboration and consultation with former patients who have received different types of treatments for OUD. In this manner, patients provided important insight to inform the selection of interventions to be evaluated, patient characteristics that may differentially impact the effects of the interventions, and the patient outcomes to be examined.
Who can join: Review the eligibility criteria below.
Location: Philadelphia College of Osteopathic Medicine — Philadelphia, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
- Psychosocial treatment (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Philadelphia College of Osteopathic Medicine — Philadelphia, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid-use Disorder
- Recovery Management Checkups for Opioid Use Disorder Experiment — Chicago, Illinois
- Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment — The Bronx, New York
- Neuromodulation and Cognitive Training in Opioid Use Disorder — Minneapolis, Minnesota
- Pilot Research on Opioid Use Disorder — San Francisco, California
- Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services — Bridgeport, Connecticut
Explore by condition: All Opioid-use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.